Contract Pharma17 分钟
Touchlight Appoints Will Downie as Key Adviser
Touchlight, a leader in synthetic DNA technology, has appointed Will Downie as a key adviser to support its mission of ...
Contract Pharma44 分钟
Merck’s WELIREG Accepted for Priority Review by FDA for Pheochromocytoma and Paraganglioma
The supplemental new drug application is based on data from the Phase 2 LITESPARK-015 trial.